Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

NCT06839235 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hyperoxaluria Type 1 (PH1)

Interventions

DRUG: ABO-101

Sponsor

Arbor Biotechnologies